CD19 / BCMA / Firefly Luciferase - CHO Recombinant Cell Line

SKU:BHC18200071
Research Validated
Overview
Click light‑blue chips for details
CD19 / BCMA / Firefly Luciferase - CHO Recombinant Cell Line is a CAR-T Cell Line (CHO background, Chinese Hamster origin, BSL-1) from BPS Bioscience. Designed for useful for validation of anti-cd19 and anti-bcma bispecific antibody. workflows.
Parental Cell Line CHO
Species Chinese Hamster
Biosafety Level BSL-1
Product Type CAR-T Cell Line
Mycoplasma Tested Confirmed Negative
Storage Liquid Nitrogen
Options selector
Catalog no. Size
78030 2 Vials
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 2 Vials
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Immediately upon receipt, store in liquid nitrogen.
  • Shipping: cold-chain shipment (typically with ice packs).
  • Upon receipt: store at the recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No 78030
Alternative Names TNFRSF17 cells, BCM cell lines, BCMA cell line, CD269 cell line, TNFRSF13A cells, B4 cell line, CVID3 cell line
Product Type
  • CAR-T Cell Line
Shipping -80°C (dry ice)
Species Chinese Hamster
Storage Immediately upon receipt, store in liquid nitrogen.

Scientific Background

B-lymphocyte antigen CD19 (Cluster of Differentiation 19), also known as B-Lymphocyte Surface Antigen B4 and CVID3, is a transmembrane protein expressed in follicular dendritic cells and all B lineage cells except plasma cells. CD19 plays two major roles in human B cells. It acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane and it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development and lymphoma diagnosis and can be used as a target for leukemia immunotherapies. CD19-targeted therapies based on T cells that express CD19-specific chimeric antigen receptors (CARs) have been utilized for their antitumor abilities in patients with CD19+ lymphoma and leukemia, such as Non-Hodgkins Lymphoma (NHL), CLL and ALL.
B-Cell Maturation Antigen (BCMA), also known as CD269, is a cell surface receptor of the TNF receptor superfamily that recognizes B-Cell Activating Factor (BAFF). BCMA is preferentially expressed on mature B-lymphocytes and Multiple Myeloma (MM) cells. BCMA is a highly attractive target antigen for immunotherapy, not only because of its restricted expression in nonmalignant tissue, but also due to its almost universal expression on MM cells. Pre-clinical studies using CAR (Chimeric Antigen Receptor) T-cells targeting BCMA have demonstrated anti-MM activity, and in 2017, the FDA granted BCMA CAR T-Cell immunotherapy the breakthrough designation in treating Multiple Myeloma.

Product Description

CAR-T

Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein (also known as B4 or CVID3, Genbank #NM_001770), human BCMA protein (B-Cell Maturation Antigen or CD269, GenBank accession #NM_001192) and the firefly luciferase. Surface expression of CD19 and BCMA were confirmed by flow cytometry.

Product Specifications

Host Cell Line CHO
Host Species Hamster
Transfection Method Lipofectamine 2000
Supplied As Each vial contains ~2 x 10^6 cells in 1 ml of 10% DMSO and 90% FBS
Harmonized Tariff Code 3002-5900

Quality Control & Validation

✓ Mycoplasma-Tested

This cell line has been screened using PlasmoTest™ - Mycoplasma Detection Kit (InvivoGen #rep-pt1) to confirm the absence of Mycoplasma species.

Safety & Handling

⚠ Avoid freeze/thaw cycles.

Regulatory Information

License RequiredYes
Living Modified OrganismYes

License Disclosure

Purchase of this cell line grants you with a 10-year license to use this cell line in your immediate laboratory, for research use only. This license does not permit you to share, distribute, sell, sublicense, or otherwise make the cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. The license does not permit the use of this cell line in humans or for therapeutic or drug use. The license does not permit modification of the cell line in any way. Inappropriate use or distribution of this cell line will result in revocation of the license and result in an immediate cease of sales and distribution of BPS products to your laboratory. BPS does not warrant the suitability of the cell line for any particular use, and does not accept any liability in connection with the handling or use of the cell line. Modifications of this cell line, transfer to another facility, or commercial use of the cells may require a separate license and additional fees; contact sales@bpsbioscience.com for details. Publications using this cell line should reference BPS Bioscience, Inc., San Diego.

Related Products

Related Products: Cat. #60186, 79500, 79724, 78041

Required Accessories: Cat. #60186,78041,79796

What is the parental cell line for this product?

This product is engineered on a CHO background (Chinese Hamster origin). The CHO host was selected for its compatibility with stable transfection and the target pathway or assay type. Consult the product datasheet for passage number guidance and recommended culture media.

What biosafety level is required for this cell line?

This product is classified as BSL-1. Standard microbiological practices (gloves, lab coat, eye protection) are sufficient. No specialized containment facility is required beyond a clean bench. Consult your institutional IBC for GMO registration requirements.

Has this cell line been tested for mycoplasma contamination?

Yes. This cell line has been screened using PlasmoTest™ - Mycoplasma Detection Kit (InvivoGen #rep-pt1) to confirm the absence of Mycoplasma species. We recommend that you independently confirm mycoplasma-negative status after receipt and periodically during routine culture using a validated detection kit.

What are the recommended storage conditions?

Store this product at Liquid Nitrogen. Specifically: Immediately upon receipt, store in liquid nitrogen. Transfer cells from dry-ice shipping to the recommended storage immediately upon receipt. Avoid repeated freeze-thaw cycles, which reduce viability and may alter expression characteristics.

Is a license required to use this product?

Yes, a license is required (Yes). Purchase of this cell line grants a time-limited research-use license for use in your immediate laboratory only. This license does not permit redistribution, sub-licensing, transfer to other institutions, or commercial use. Refer to the License Disclosure section on this page or contact BPS Bioscience for details regarding modifications or commercial licensing.

What method was used to generate this cell line?

This stable cell line was generated using Lipofectamine 2000 for transgene delivery into the parental host. The stably integrated cells were selected using the appropriate resistance marker and verified for expression prior to cryopreservation.

Can't find the cell line you need—or require a custom engineered model for your study? We offer end-to-end support for diverse research needs, including:

  • Cell line sourcing and selection (species, tissue, and disease model matching)
  • Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA)
  • Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs)
  • Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles)
  • Inducible expression systems (Tet-On/Off and regulatable constructs)
  • Drug resistance marker selection (puromycin, G418, hygromycin, and others)
  • Custom growth and media optimisation for specific assay requirements
  • Scale-up production for high-throughput screening campaigns
  • Authentication and QC services (STR profiling, mycoplasma testing, viability assessment)

Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

  1. Kang, L., et al.
  2. Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma. Biomark Res. (8):14
  3. D'Agostino, M., et al.
  4. Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? Leukemia 34:21-34.
  5. Sadelain, M.
  6. CD19 CAR T Cells. Cell 171(7):1471
Matches this product
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today